Orajel, Dermarest Line Extension Ad Support Slated For September
This article was originally published in The Tan Sheet
Executive Summary
Del Laboratories will promote its new Orajel Multi Action Cold Sore Medicine by offering a $3 rebate to any consumer who mails the company proof-of-purchase for any cough/cold product.
You may also be interested in...
Del Labs
Net sales jumped 14.6% to $87.9 mil. in Q2, primarily driven by "continued growth" in Orajel line, cosmetics segment, firm says. Net income for quarter was $3.3 mil., up 74% compared to earnings of $1.9 mil. last year. Six-month sales totaled $160.7 mil., rising 11.4% over prior-year period. Orajel Multi Action Cold Sore Medicine shipped in June, along with new products in Dermarest Psoriasis line; TV ads slated to break in September (1"The Tan Sheet" May 7, p. 5)
Del Labs
Net sales jumped 14.6% to $87.9 mil. in Q2, primarily driven by "continued growth" in Orajel line, cosmetics segment, firm says. Net income for quarter was $3.3 mil., up 74% compared to earnings of $1.9 mil. last year. Six-month sales totaled $160.7 mil., rising 11.4% over prior-year period. Orajel Multi Action Cold Sore Medicine shipped in June, along with new products in Dermarest Psoriasis line; TV ads slated to break in September (1"The Tan Sheet" May 7, p. 5)
Del Labs
Net sales jumped 14.6% to $87.9 mil. in Q2, primarily driven by "continued growth" in Orajel line, cosmetics segment, firm says. Net income for quarter was $3.3 mil., up 74% compared to earnings of $1.9 mil. last year. Six-month sales totaled $160.7 mil., rising 11.4% over prior-year period. Orajel Multi Action Cold Sore Medicine shipped in June, along with new products in Dermarest Psoriasis line; TV ads slated to break in September (1"The Tan Sheet" May 7, p. 5)